基于网络药理学三芪口服液治疗糖尿病肾病的作用机制(5)
[23] Assmann TS，Recamonde-Mendoza M，Costa AR，et al. Circulating miRNAs in diabetic kidney disease：case-control study and in silico analyses [J]. Acta Diabetol，2019，56(1)：55-65.
[24] Kuo HL，Huang CC，Lin TY，et al. IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy [J]. Nephrol Dial Transplant，2018，33(2)：248-256.
[25] Ma J，Li YJ，Chen X，et al. Interleukin 17A promotes diabetic kidney injury [J]. Sci Rep，2019，9(1)：2264.
[26] Cortvrindt C，Speeckaert R，Moerman A，et al. The role of interleukin-17A in the pathogenesis of kidney diseases [J]. Pathology，2017，49(3)：247-258.
[27] Mohamed R，Jayakumar C，Chen F，et al. Low-dose IL-17 therapy prevents and reverses diabetic nephropathy，metabolic syndrome，and associated organ fibrosis [J]. J Am Soc Nephrol，2016，27(3)：745-765.
[28] Galvan DL，Danesh FR. Paradoxical role of IL-17 in progression of diabetic nephropathy [J]. J Am Soc Nephrol，2016，27(3)：657-658.
[29] Nayak BK，Shanmugasundaram K，Friedrichs WE，et al. HIF-1 mediates renal fibrosis in OVE26 type 1 diabetic mice [J]. Diabetes，2016，65(5)：1387-1397.
[30] Persson P，Palm F. Hypoxia-inducible factor activation in diabetic kidney disease [J]. Curr Opin Nephrol Hypertens，2017，26(5)：345-350.
(收稿日期：2019-05-10 本文編辑：李亚聪), http://www.100md.com(林嘉荣 张蕾 桂定坤 曾贵兴 吴禹池 邹川 林启展)
[24] Kuo HL，Huang CC，Lin TY，et al. IL-17 and CD40 ligand synergistically stimulate the chronicity of diabetic nephropathy [J]. Nephrol Dial Transplant，2018，33(2)：248-256.
[25] Ma J，Li YJ，Chen X，et al. Interleukin 17A promotes diabetic kidney injury [J]. Sci Rep，2019，9(1)：2264.
[26] Cortvrindt C，Speeckaert R，Moerman A，et al. The role of interleukin-17A in the pathogenesis of kidney diseases [J]. Pathology，2017，49(3)：247-258.
[27] Mohamed R，Jayakumar C，Chen F，et al. Low-dose IL-17 therapy prevents and reverses diabetic nephropathy，metabolic syndrome，and associated organ fibrosis [J]. J Am Soc Nephrol，2016，27(3)：745-765.
[28] Galvan DL，Danesh FR. Paradoxical role of IL-17 in progression of diabetic nephropathy [J]. J Am Soc Nephrol，2016，27(3)：657-658.
[29] Nayak BK，Shanmugasundaram K，Friedrichs WE，et al. HIF-1 mediates renal fibrosis in OVE26 type 1 diabetic mice [J]. Diabetes，2016，65(5)：1387-1397.
[30] Persson P，Palm F. Hypoxia-inducible factor activation in diabetic kidney disease [J]. Curr Opin Nephrol Hypertens，2017，26(5)：345-350.
(收稿日期：2019-05-10 本文編辑：李亚聪), http://www.100md.com(林嘉荣 张蕾 桂定坤 曾贵兴 吴禹池 邹川 林启展)